Generics makers appeal ruling on patents for Pozen's Treximet

09/8/2011 | MedCityNews.com

Alphapharm, Dr. Reddy's Laboratories and Par Pharmaceutical appealed a court decision that upholds patents covering Pozen's migraine drug Treximet. The ruling blocks FDA approval of the firms' generic versions before patent expiration.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD